@ Ashok Yadav | Editor
New Delhi: Corona virus is spreading rapidly in the country at this time. In such a situation a good news has come from Mumbai here a pharmaceutical company named Glenmark Pharmaceuticals has developed a drug. Which the company has claimed. With the help of this, patients suffering from corona moderately can be cured with this medicine. The company has introduced this drug to Favipiravir under the brand name Fabiflu.
FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement.
“This approval comes at a time when cases in India are spiralling like never before, putting a tremendous pressure on our healthcare system,” Glenmark Pharmaceuticals Chairman and Managing Director Glenn Saldanha said.
The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer patients in India a much needed and timely therapy option, he added.
FabiFlu has demonstrated an encouraging response in mild to moderate COVID-19 patients during clinical trials, Saldanha said.
Moreover, it is orally administered, and so it serves as a more convenient treatment option over other intravenously administered medications, he noted.
“Glenmark will work closely with the government and medical community to make FabiFlu quickly accessible to patients across the country,” Saldanha said.
“This approval comes at a time when cases in India are spiralling like never before, putting a tremendous pressure on our healthcare system,” Glenmark Pharmaceuticals Chairman and Managing Director Glenn Saldanha said.
The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer patients in India a much needed and timely therapy option, he added.
Let us know in clinical trials that this drug has shown good effect on mild patients of corona virus. The company has said that it is best that this medicine is a food drug, it can be given to patients very easily. The company has kept the rate of one tablet of this medicine at Rs 103 per tablet.
The company has told that patients suffering from diabetes and heart disease can also take this medicine easily. On the first day, the patient will have to take two doses of 1800 mg of it and 2 doses of 800 mg for 14 days. The number of corona patients in the country has now reached 3,95,000 and on Saturday, 14,516 new cases of corona were reported in a day.
